A detailed history of Marshall Wace, LLP transactions in Pfizer Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 5,378,173 shares of PFE stock, worth $148 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,378,173
Previous 3,000,000 79.27%
Holding current value
$148 Million
Previous $83.3 Million 80.76%
% of portfolio
0.21%
Previous 0.13%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $136 Million - $159 Million
5,378,173 New
5,378,173 $150 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $43.8 Million - $56.9 Million
-1,676,211 Reduced 69.57%
733,287 $21.1 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $64.7 Million - $75.7 Million
2,017,709 Added 515.0%
2,409,498 $79.9 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $12 Million - $13.8 Million
331,231 Added 546.96%
391,789 $14.4 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $24.4 Million - $31.7 Million
-619,116 Reduced 91.09%
60,558 $2.47 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $140 Million - $183 Million
-3,351,413 Reduced 83.14%
679,674 $34.8 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $95 Million - $116 Million
-2,172,001 Reduced 35.01%
4,031,087 $176 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $178 Million - $212 Million
3,836,099 Added 162.07%
6,203,088 $325 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $135 Million - $168 Million
-2,960,742 Reduced 55.57%
2,366,989 $123 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $156 Million - $231 Million
3,778,140 Added 243.82%
5,327,731 $315 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $59.3 Million - $76.2 Million
1,510,477 Added 3861.73%
1,549,591 $66.6 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $28.4 Million - $32.2 Million
-791,097 Reduced 95.29%
39,114 $1.53 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $27.8 Million - $31.4 Million
830,211 New
830,211 $30.1 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $13.6 Million - $16.4 Million
-450,046 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $74.3 Million - $106 Million
-2,746,985 Reduced 85.92%
450,046 $14.7 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $63.9 Million - $72.5 Million
1,940,246 Added 154.38%
3,197,031 $125 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $40.8 Million - $52.9 Million
1,256,785 New
1,256,785 $45.2 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $24.2 Million - $27.2 Million
-655,261 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $1.71 Million - $1.88 Million
-45,570 Reduced 6.5%
655,261 $27.8 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $25.1 Million - $28.6 Million
652,622 Added 1353.73%
700,831 $30.6 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $297,820 - $361,238
-8,640 Reduced 15.2%
48,209 $2.13 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $862,229 - $919,223
-26,144 Reduced 31.5%
56,849 $2.06 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.05 Million - $1.22 Million
32,973 Added 65.92%
82,993 $2.95 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $63,027 - $66,874
1,895 Added 3.94%
50,020 $1.81 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.49 Million - $1.64 Million
48,125
48,125 $1.73 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.